| Genome-wide analysis uncovers novel recurrent alterations in primary central nervous system lymphomas E Braggio, S Van Wier, J Ojha, E McPhail, YW Asmann, J Egan, ... Clinical Cancer Research 21 (17), 3986-3994, 2015 | 235 | 2015 |
| Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M3P) KM Kortüm, C Langer, J Monge, L Bruins, YX Zhu, CX Shi, P Jedlowski, ... Annals of hematology 94, 1205-1211, 2015 | 108 | 2015 |
| Sequestration of toxic oligomers by HspB1 as a cytoprotective mechanism J Ojha, G Masilamoni, D Dunlap, RA Udoff, AG Cashikar Molecular and cellular biology 31 (15), 3146-3157, 2011 | 107 | 2011 |
| Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk KM Walsh, V Codd, T Rice, CP Nelson, IV Smirnov, LS McCoy, ... Oncotarget 6 (40), 42468, 2015 | 100 | 2015 |
| GWAS in childhood acute lymphoblastic leukemia reveals novel genetic associations at chromosomes 17q12 and 8q24. 21 JL Wiemels, KM Walsh, AJ de Smith, C Metayer, S Gonseth, HM Hansen, ... Nature communications 9 (1), 286, 2018 | 89 | 2018 |
| Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome S Barrio, TD Shanafelt, J Ojha, KG Chaffee, C Secreto, KM Kortüm, ... Leukemia 31 (1), 170-176, 2017 | 81 | 2017 |
| Genetic variation associated with longer telomere length increases risk of chronic lymphocytic leukemia J Ojha, V Codd, CP Nelson, NJ Samani, IV Smirnov, NR Madsen, ... Cancer Epidemiology, Biomarkers & Prevention 25 (7), 1043-1049, 2016 | 77 | 2016 |
| Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia J Ojha, J Ayres, C Secreto, R Tschumper, K Rabe, D Van Dyke, S Slager, ... Blood, The Journal of the American Society of Hematology 125 (3), 492-498, 2015 | 76 | 2015 |
| Targeted sequencing using a 47 gene multiple myeloma mutation panel (M3P) in ‐17p high risk disease KM Kortüm, C Langer, J Monge, L Bruins, JB Egan, YX Zhu, CX Shi, ... British journal of haematology 168 (4), 507-510, 2015 | 62 | 2015 |
| Identification of recurrent truncated DDX3X mutations in chronic lymphocytic leukaemia J Ojha, CR Secreto, KG Rabe, DL Van Dyke, KM Kortum, SL Slager, ... British journal of haematology 169 (3), 445, 2014 | 61 | 2014 |
| Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression J Ojha, C Secreto, K Rabe, J Ayres-Silva, R Tschumper, DV Dyke, ... Leukemia 28 (12), 2395-2398, 2014 | 57 | 2014 |
| Behavioral defects in chaperone-deficient Alzheimer's disease model mice J Ojha, RV Karmegam, JG Masilamoni, AV Terry Jr, AG Cashikar PloS one 6 (2), e16550, 2011 | 50 | 2011 |
| TIMP-1 downregulation modulates miR-125a-5p expression and triggers the apoptotic pathway S Ghoshal-Gupta, A Kutiyanawalla, BR Lee, J Ojha, A Nurani, AK Mondal, ... Oncotarget 9 (10), 8941, 2018 | 20 | 2018 |
| Genomic characterization of chronic lymphocytic leukemia (CLL) in radiation-exposed Chornobyl cleanup workers J Ojha, I Dyagil, SC Finch, RF Reiss, AJ de Smith, S Gonseth, M Zhou, ... Environmental Health 17, 1-9, 2018 | 17 | 2018 |
| Clonal and microclonal mutational heterogeneity in high hyperdiploid acute lymphoblastic leukemia AJ de Smith, J Ojha, SS Francis, E Sanders, AA Endicott, HM Hansen, ... Oncotarget 7 (45), 72733, 2016 | 14 | 2016 |
| The genomic landscape of primary central nervous system lymphomas E Braggio, BP O'Neill, S Van Wier, J Ojha, R Valdez, J Egan, E McPhail, ... Blood 122 (21), 504, 2013 | 2 | 2013 |
| Genome-wide analysis uncovers recurrent alterations in primary central nervous system lymphomas (PCNSL) BP O'Neill, E Braggio, BP O'Neill, S Van Wier, J Ojha, E McPhail, ... Neuro-Oncology 16 (Suppl 3), iii43, 2014 | 1 | 2014 |
| Clonal and microclonal mutational heterogeneity in high hyperdiploid acute lymphoblastic AJ de Smith, J Ojha, SS Francis Oncotarget, 7 (45), 2016 | | 2016 |
| GENOMIC CHARACTERIZATION OF HIGH-COUNT MBL INDIVIDUALS INDICATES THAT EARLY DETECTION OF DRIVER MUTATIONS AND SUBCLONAL EXPANSION ARE PREDICTORS OF ADVERSE CLINICAL OUTCOME S Barrio, KM Kortuem, J Ojha, C Secreto, K Chaffee, S Pathangey, ... HAEMATOLOGICA 101, 45-45, 2016 | | 2016 |
| Mutations in Driver Genes and Changes in Clonal Dynamics Are Associated with Shorter Time to Treatment in MBL Cases S Barrio, J Ojha, C Secreto, KG Chaffee, S Pathangey, SL Slager, ... Blood 126 (23), 5264, 2015 | | 2015 |
